Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection

Patients with anti–IFN-γ autoantibodies have impaired IFN-γ signaling, leading to severe disseminated infections with intracellular pathogens, especially nontuberculous mycobacteria. Disease may be severe and progressive, despite aggressive treatment. To address the underlying pathogenic IFN-γ autoa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Browne, Sarah K., Zaman, Rifat, Sampaio, Elizabeth P., Jutivorakool, Kamonwan, Rosen, Lindsey B., Ding, Li, Pancholi, Minjal J., Yang, Lauren M., Priel, Debra Long, Uzel, Gulbu, Freeman, Alexandra F., Hayes, Carlton E., Baxter, Roger, Cohen, Stuart H., Holland, Steven M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2012
Pynciau:
Clinical Trials and Observations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350360/
https://ncbi.nlm.nih.gov/pubmed/22403254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-395707
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg